The use of stem cells in liver disease

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 64-71

  Flohr, Tanya R ^a   Bonatti, Hugo J R ^a   Brayman, Kenneth L ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Acute liver failure; Cirrhosis; Liver disease; Stem cell; Transplantation

Indexed keywords

AUTOTRANSPLANTATION; CELL REGENERATION; EMBRYONIC STEM CELL; GRAFT REJECTION; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; LIVER RESECTION; LIVER TUMOR; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; REVIEW; STEM CELL TRANSPLANTATION; ADULT; ANIMAL; ANIMAL MODEL; ARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL PROLIFERATION; LIVER REGENERATION; PATHOPHYSIOLOGY; REGENERATIVE MEDICINE; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER REGENERATION; LIVER, ARTIFICIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MODELS, ANIMAL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 67649210775     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328320fd7b     Document Type: Review

References (93)

1. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110:1001-1020.
2. Marubashi S, Sakon M, Nagano H, et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 2004; 136:1028-1037. (Pubitemid 39452303)
3. Khan Z, Michalopoulos GK, Stolz DB. Peroxisomal localization of hypoxia-inducible factors and hypoxia-inducible factor regulatory hydroxylases in primary rat hepatocytes exposed to hypoxia-reoxygenation. Am J Pathol 2006; 169:1251-1269. (Pubitemid 351194361)
4. Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007; 18:819-826. An excellent review of hepatocytes, LPCs, MSCs and ESCs for liver therapy.
5. Overturf K, al-Dhalimy M, Ou CN, et al. Serial transplantation reveals the stem-cell- like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997; 151:1273-1280. (Pubitemid 27479757)
6. Rabes HM. Kinetics of hepatocellular proliferation as a function of the microvascular structure and functional state of the liver. Ciba Found Symp 1977; 55:31-53.
7. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213:286-300. A review of the hepatocyte response to injury and the process of liver regeneration.
8. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274:1379-1383.
9. Fausto N, Riehle KJ. Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg 2005; 12:181-189. (Pubitemid 40975518)
10. Sakamoto T, Liu Z, Murase N, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999; 29:403-411. (Pubitemid 29088443)
11. Arkadopoulos N, Chen SC, Khalili TM, et al. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Cell Transplant 1998; 7:357-363. (Pubitemid 28346165)
12. De Vree JM, Ottenhoff R, Bosma PJ, et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000; 119:1720-1730. (Pubitemid 32198697)
13. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338:1422-1426. (Pubitemid 28221983)
14. Gagandeep S, Rajvanshi P, Sokhi RP, et al. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. J Pathol 2000; 191:78-85. (Pubitemid 30235653)
15. Gagandeep S, Sokhi R, Slehria S, et al. Hepatocyte transplantation improves survival in mice with liver toxicity induced by hepatic overexpression of Mad1 transcription factor. Mol Ther 2000; 1:358-365.
16. Groth CG, Arborgh B, Bjorken C, et al. Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc 1977; 9:313-316.
17. Hadjantonakis AK, Gertsenstein M, Ikawa M, et al. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998; 76:79-90. (Pubitemid 28467905)
18. Horslen SP, McCowan TC, Goertzen TC, et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003; 111 (6 Pt 1):1262-1267.
19. Kobayashi N, Ito M, Nakamura J, et al. Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant 2000; 9:671-673. (Pubitemid 32002573)
20. Kocken JM, Borel Rinkes IH, Bijma AM, et al. Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation 1996; 62:358-364.
21. Krishna Vanaja D, Sivakumar B, Jesudasan RA, et al. In vivo identification, survival, and functional efficacy of transplanted hepatocytes in acute liver failure mice model by FISH using Y-chromosome probe. Cell Transplant 1998; 7:267-273.
22. Nakamura J, Okamoto T, Schumacher IK, et al. Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. Transplantation 1997; 63:1541-1547. (Pubitemid 27265491)
23. Oertel M, Rosencrantz R, Chen YQ, et al. Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology 2003; 37:994-1005. (Pubitemid 36538676)
24. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996; 12:266-273. (Pubitemid 26080085)
25. Rajvanshi P, Kerr A, Bhargava KK, et al. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology 1996; 23:482-496. (Pubitemid 126664266)
26. Sommer BG, Sutherland DE, Simmons RL, Najarian JS. Hepatocellular transplantation for experimental ischemic acute liver failure in dogs. J Surg Res 1980; 29:319-325. (Pubitemid 10025528)
27. Sutherland DE, Numata M, Matas AJ, et al. Hepatocellular transplantation in acute liver failure. Surgery 1977; 82:124-132. (Pubitemid 8127013)
28. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416:542-545. (Pubitemid 34288856)
29. Wiederkehr JC, Kondos GT, Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 1990; 50:466-471.
30. Yoshida Y, Tokusashi Y, Lee GH, Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 1996; 111:1654-1660. (Pubitemid 26404231)
31. Matas AJ, Sutherland DE, Steffes MW, et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 1976; 192:892-894.
32. Michel JL, Rabier D, Rambaud C, et al. Intrasplenic transplantation of hepatocytes in spf-ash mice with congenital ornithine transcarbamylase deficiency. Chirurgie 1993; 119:666-671. (Pubitemid 24367233)
33. Gupta S, Chowdhury NR, Jagtiani R, et al. A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation 1990; 50:472-475. (Pubitemid 20309872)
34. Ponder KP, Gupta S, Leland F, et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 1991; 88:1217-1221. (Pubitemid 21916196)
35. Rozga J, Holzman M, Moscioni AD, et al. Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 1995; 4:237-243.
36. Laconi E, Oren R, Mukhopadhyay DK, et al. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 1998; 153:319-329. (Pubitemid 28317536)
37. Dan YY, Yeoh GC. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 2008; 23:687-698. An excellent review of hepatocytes, LPCs, MSCs and ESCs for liver therapy.
38. Hochleitner B, Hengster P, Duo L, et al. A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity. Artif Organs 2005; 29:58-66. (Pubitemid 41602005)
39. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992; 24:3052-3053.
40. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999; 19:39-48. (Pubitemid 29220830)
41. Faenza S, Baraldi O, Bernardi M, et al. Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008; 40:1169-1171. A review of LPCs and their response to liver injury compared with mature hepatocytes. (Pubitemid 351794319)
42. Phua J, Lee KH. Liver support devices. Curr Opin Crit Care 2008; 14:208-215.
43. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis 2008; 28:210-217.
44. Sechser A, Osorio J, Freise C, Osorio RW. Artificial liver support devices for fulminant liver failure. Clin Liver Dis 2001; 5:415-430. (Pubitemid 32472565)
45. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32 (1 Suppl):63-76. (Pubitemid 30123625)
46. Puppi J, Tan N, Mitry RR, et al. Hepatocyte transplantation followed by auxiliary liver transplantation: a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 2008; 8:452-457.
47. Grossman M, Rader DJ, Muller DW, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995; 1:1148-1154.
48. Strom SC, Fisher RA, Rubinstein WS, et al. Transplantation of human hepatocytes. Transplant Proc 1997; 29:2103-2106.
49. Dhawan A, Mitry RR, Hughes RD, et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004; 78:1812-1814. (Pubitemid 40041650)
50. Thompson R, Strautnieks S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001; 21:545-550. (Pubitemid 33131046)
51. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 2006; 29 (2-3):431-435. (Pubitemid 43880647)
52. Kinosita R. Studies on the cancerogenic chemical substances. Trans Japanese Pathol Soc 1937; 27:665-727.
53. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998; 27:433-445.
54. Jelnes P, Santoni-Rugiu E, Rasmussen M, et al. Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology 2007; 45:1462-1470. (Pubitemid 46918330)
55. Petersen BE, Grossbard B, Hatch H, et al. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 2003; 37:632-640. (Pubitemid 36258785)
56. Oertel M, Menthena A, Chen YQ, et al. Purification of fetal liver stem/ progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 2008; 134:823-832. A recent study that describes the repopulation of adult liver using LPCs. (Pubitemid 351312738)
57. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154:537-541.
58. Akhurst B, Matthews V, Husk K, et al. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 2005; 41:327-335. (Pubitemid 40165376)
59. Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994; 264:965-968. (Pubitemid 24196167)
60. Hu B, Colletti LM. Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2008; 295:G45-G53.
61. Knight B, Yeoh GC, Husk KL, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000; 192:1809-1818. (Pubitemid 32049773)
62. Lowes KN, Croager EJ, Abraham LJ, et al. Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut 2003; 52:1327-1332.
63. Sanchez A, Factor VM, Espinoza LA, et al. In vitro differentiation of rat liver derived stem cells results in sensitization to TNFalpha-mediated apoptosis. Hepatology 2004; 40:590-599.
64. Suzuki A, McCall S, Choi SS, et al. Interleukin-15 increases hepatic regenerative activity. J Hepatol 2006; 45:410-418. (Pubitemid 44142113)
65. Viebahn CS, Tirnitz-Parker JE, Olynyk JK, Yeoh GC. Evaluation of the 'Cellscreen' system for proliferation studies on liver progenitor cells. Eur J Cell Biol 2006; 85:1265-1274.
66. Zheng D, Oh SH, Jung Y, Petersen BE. Oval cell response in 2-acetylamino- fluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1. Am J Pathol 2006; 169:2066-2074. (Pubitemid 351181966)
67. Soto-Gutierrez A, Navarro-Alvarez N, Zhao D, et al. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2007; 2:347-356. In-vitro differentiation of ESCs into a hepatocyte-like phenotype and subsequent evaluation of liver function are discussed in this article.
68. Yamamoto H, Quinn G, Asari A, et al. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 2003; 37:983-993. (Pubitemid 36538675)
69. Fujino H, Hiramatsu H, Tsuchiya A, et al. Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma(c)null mice through cell fusion. FASEB J 2007; 21:3499-3510.
70. Evarts RP, Hu Z, Fujio K, et al. Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ 1993; 4:555-561.
71. Snykers S, De Kock J, Vanhaecke T, Rogiers V. Differentiation of neonatal rat epithelial cells from biliary origin into immature hepatic cells by sequential exposure to hepatogenic cytokines and growth factors reflecting liver development. Toxicol In Vitro 2007; 21:1325-1331. (Pubitemid 350026234)
72. Swenson ES, Kuwahara R, Krause DS, Theise ND. Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int 2008; 28:308-318. (Pubitemid 351279578)
73. Yasui O, Miura N, Terada K, et al. Isolation of oval cells from Long-Evans cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology 1997; 25:329-334. (Pubitemid 27069051)
74. Li WL, Su J, Yao YC, et al. Isolation and characterization of bipotent liver progenitor cells from adult mouse. Stem Cells 2006; 24:322-332. (Pubitemid 44464801)
75. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163:1301-1311. (Pubitemid 37175079)
76. Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204:1973-1987. A description of the isolation of human LPCs using EPCAM and NCAM. (Pubitemid 47236331)
77. Pavlic M, Libiseller K, Hermann M, et al. Small human hepatocytes in rotary culture for treatment of alcohol addicts? A pilot study. Alcohol Clin Exp Res 2007; 31:729-736. (Pubitemid 46587654)
78. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3:393-403.
79. Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40:1275-1284.
80. Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134:2111-2121; 21 e1-3.
81. Yagi K, Kojima M, Oyagi S, et al. Application of mesenchymal stem cells to liver regenerative medicine. Yakugaku Zasshi 2008; 128:3-9.
82. Yu Y, Yao AH, Chen N, et al. Mesenchymal stem cells over-expressing hepatocyte growth factor improve small-for-size liver grafts regeneration. Mol Ther 2007; 15:1382-1389. (Pubitemid 46965334)
83. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008; 47:1634-1643. (Pubitemid 351702746)
84. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229-1234. (Pubitemid 30950849)
85. am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005; 23:463-470.
86. Wang Z, Lu H, Wang YC, Cong XQ. Human embryonic stem cells and liver diseases: from basic research to future clinical application. J Dig Dis 2008; 9:14-19. A discussion of ESCs' potential applications for liver disease therapy. (Pubitemid 351188935)
87. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007; 45:1229-1239. In this article, in-vitro differentiation of ESCs into a hepatocyte-like phenotype and subsequent transplantation are explained.
88. Rambhatla L, Chiu CP, Kundu P, et al. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003; 12:1-11. (Pubitemid 36397310)
89. Teratani T, Yamamoto H, Aoyagi K, et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 2005; 41:836-846. (Pubitemid 40462947)
90. Heo J, Factor VM, Uren T, et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006; 44:1478-1486. (Pubitemid 44953653)
91. Ishii T, Yasuchika K, Machimoto T, et al. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells 2007; 25:3252-3260. (Pubitemid 350294451)
92. Cho CH, Parashurama N, Park EY, et al. Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J 2008; 22:898-909. Description of ESCs used in the bioartificial liver to treat fulminant hepatic failure. (Pubitemid 351348141)
93. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 2006; 24:1412-1419. (Pubitemid 44722105)